NIGMS RO1, PI: Tao Lu, Ph.D. Title: Gene-specific responses to NF-?B through lysine and arginine methylation of p65 Abstract: Activation of the multi-functional transcription factor nuclear factor ?B (NF-?B), a central coordinator of immune responses, is tightly regulated in order to achieve its normal transient activation in response to stress. In many pathologies, NF-?B is activated abnormally, contributing to the development of a variety of disorders, including lung disease, chronic inflammatory diseases, cardiovascular disease, diabetes, and cancer. Thus, drugs that block NF-?B activation could be effective in treating these diseases. Understanding the molecular mechanism of NF-?B activation is the first step toward our long-term goal of identifying novel therapeutics. This proposal focuses on methylation as a novel mechanism ensuring precise control of NF-?B activity at its target genes. Recently, we discovered that lysine residues 218/221 (K218/221) and arginine residue 30 (R30) of the p65 subunit of NF-?B are methylated by histone-modifying enzymes. Our central hypothesis is that p65 R30 and K218/221 methylation differentially regulates NF-?B-dependent gene expression by affecting promoter binding, recruitment of transcriptional modifiers, and the physical properties of the NF-?B:DNA interaction. To test this central hypothesis, we will pursue two specific aims:
Aim 1 : Dissect the distinct impacts of p65 R30 and K218/221 methylation on the critical molecular events that lead to differential gene regulation.
Aim 2 : Determine the structural consequences of p65 R30 methylation, and discover the mechanisms of NF-?B-DNA sequence- specific effects on target gene promoters. Significance: The important findings from this study will identify the molecular mechanisms underlying p65 methylation-dependent gene-specific regulation, thus revealing how the extreme plasticity of biological responses is regulated by NF-?B, and offering deep insights into the development of NF-?B-associated diseases as well as innovative strategies for their therapeutic intervention.

Public Health Relevance

NIGMS R01, PI: Tao Lu, Ph.D. Title: Gene-specific responses to NF-?B through lysine and arginine methylation of p65 Project Narrative: The important transcription factor NF-?B is a key link between inflammation and many pathological conditions. Aberrant expression of NF-?B occurs in a variety of diseases. This proposal focuses on methylation of the NF- ?B subunit p65 as a novel mechanism used by cells to precisely control NF-?B activity at its target genes. The important findings from this study will identify the molecular mechanisms underlying p65 methylation-dependent gene-specific regulation, thus revealing how a multitude of biological responses is regulated by NF-?B, and offering innovative strategies for therapeutic intervention in a broad range of NF-?B-associated diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM120156-03S1
Application #
10145947
Study Section
Program Officer
Carter, Anthony D
Project Start
2017-09-15
Project End
2022-08-31
Budget Start
2019-09-01
Budget End
2020-08-31
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Pharmacology
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202